Multiple Sclerosis Clinical Trial

Technology-assisted Conscientiousness Therapy for People With Multiple Sclerosis

Summary

This is a validation study of a conscientiousness-based phone app intervention strategy to help people with their health management and employment.

View Full Description

Full Description

The primary objective is to establish whether people with MS with low Conscientiousness benefit from a cognitive-behavioral, phone app intervention. The investigators also aim to determine the acceptability and utilization of the Conscientiousness-Coach phone application and intervention. It is anticipated that the Conscientiousness-Coach phone app intervention will result in fewer negative work events and increased work accommodations in those treated, relative to the control group. In exploration of other secondary outcomes, the investigators also expect that the treatment will result in increased self-report trait Conscientiousness itself, increase in structured leisure activities, reduction in depression, and reduction in anxiety.

This is a prospective longitudinal design with an experimental manipulation (i.e., a randomized-controlled trial). There will be an initial assessment with neuropsychological testing, the Buffalo Vocational Monitoring Survey (BVMS), and several self-report measures, and a post-test assessment after three months and six months with these same instruments, excluding the neuropsychological assessment. The BVMS will also be administered at 0 months, 3 months, and 6 months to further assess post-treatment effects.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Has a diagnosis of Multiple Sclerosis.
Is above 18 years of age.
Is currently employed full- or part- time
No history of substance dependence/abuse, psychiatric disorders, or any neurological disease other than MS
Has a NEO-FFI Conscientiousness score that is one standard deviation or more below the healthy adult mean (t=40)

Exclusion Criteria:

Does not meet one or more of the above inclusion criteria
Has NEO-FFI Conscientiousness score above t=40

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

60

Study ID:

NCT04953689

Recruitment Status:

Recruiting

Sponsor:

State University of New York at Buffalo

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Conventus Building
Buffalo New York, 14203, United States More Info
Michael Jaworski, BA
Contact

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

60

Study ID:

NCT04953689

Recruitment Status:

Recruiting

Sponsor:


State University of New York at Buffalo

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.